Search research articles
Contact Us
Filters
Showing results (71-80 of 143) with videos related to
Page
of 15
Sort By:
Current Vascular Pharmacology
|
August 24, 2004
Endothelial therapy of atherosclerosis and its risk factors
Tobias Traupe, Jana Ortmann, Klaus Münter, et al.
Steroids
|
September 14, 2019
Nox1 downregulators: A new class of therapeutics
Matthias Barton, Matthias R Meyer, Eric R Prossnitz
Vascular Pharmacology
|
July 12, 2011
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function
Matthias R Meyer, Eric R Prossnitz, Matthias Barton
Life Sciences
|
January 3, 2014
Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging
Matthias R Meyer, Matthias Barton, Eric R Prossnitz
Journal of Cardiovascular Pharmacology
|
April 26, 2013
Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation
Matthias Barton, Matthias R Meyer, Eric R Prossnitz
Hypertension (Dallas, Tex. : 1979)
|
March 8, 2002
Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases
Rudolf Locher, Ralf P Brandes, Wilhelm Vetter, et al.
Cardiology in Review
|
February 21, 2013
Endothelin in coronary artery disease and myocardial infarction
Theofilos M Kolettis, Matthias Barton, David Langleben, et al.
Life Sciences
|
July 31, 2012
Endothelin XII
Matthias Barton, Masashi Yanagisawa, Paul M Vanhoutte, et al.
Cardiovascular Research
|
April 12, 2005
Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen
Raghvendra K Dubey, Bruno Imthurn, Matthias Barton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 30, 2023
Post-Transcriptional and Epigenetic Regulation of Estrogen Signaling
Andrea Cignarella, Carlotta Boscaro, Mattia Albiero, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 143) with videos related to
Sort By:
Page
of 15
Current Vascular Pharmacology
|
August 24, 2004
Endothelial therapy of atherosclerosis and its risk factors
Tobias Traupe, Jana Ortmann, Klaus Münter, et al.
Steroids
|
September 14, 2019
Nox1 downregulators: A new class of therapeutics
Matthias Barton, Matthias R Meyer, Eric R Prossnitz
Vascular Pharmacology
|
July 12, 2011
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function
Matthias R Meyer, Eric R Prossnitz, Matthias Barton
Life Sciences
|
January 3, 2014
Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging
Matthias R Meyer, Matthias Barton, Eric R Prossnitz
Journal of Cardiovascular Pharmacology
|
April 26, 2013
Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation
Matthias Barton, Matthias R Meyer, Eric R Prossnitz
Hypertension (Dallas, Tex. : 1979)
|
March 8, 2002
Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases
Rudolf Locher, Ralf P Brandes, Wilhelm Vetter, et al.
Cardiology in Review
|
February 21, 2013
Endothelin in coronary artery disease and myocardial infarction
Theofilos M Kolettis, Matthias Barton, David Langleben, et al.
Life Sciences
|
July 31, 2012
Endothelin XII
Matthias Barton, Masashi Yanagisawa, Paul M Vanhoutte, et al.
Cardiovascular Research
|
April 12, 2005
Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen
Raghvendra K Dubey, Bruno Imthurn, Matthias Barton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 30, 2023
Post-Transcriptional and Epigenetic Regulation of Estrogen Signaling
Andrea Cignarella, Carlotta Boscaro, Mattia Albiero, et al.
Page
of 15